Nice (NICE) is expanding its share repurchase program, with the board of directors approving a new $500 million program. It plans to accelerate share buyback under the current $300 million program.NICE has been aggressively acquiring shares in the past three years. In 2021, 2022 and 2023, Nice bought shares worth $73 million, $145 million, and $288 million, respectively. In the first quarter of 2024, NICE used $41.5 million to buy back shares.The latest program reflects the company’s commitment to continuou ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nice. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

Nice (NICE) has been on a downward spiral lately with significant selling pressure. After declining 27.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is over ...

Nice (NICE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this software company have returned -19.7% over the past month versus the Zacks S&P 500 composite's +3.2% change. The Zacks Internet - Software industry, to which Nice belongs, has lost 0.4% over this period. Now the key question is: Where could the stock be headed in the near term? While media releases or ru ...

Nice (NICE) is expanding its footprint in the global public sector with the recent deployment of the NICE Inform solution within Italy’s national police force, the Carabinieri.Headquartered in Rome and comprising 110,000 sworn officers, the Carabinieri will utilize the NICE Inform solution across 514 emergency communication centers, which handle more than seven million emergency calls annually.By implementing NICE Inform, a pivotal component of the NICE Evidencentral platform, which is already used by more ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Nice (NICE) .Nice currently has an average brokerage recommendation (ABR) ...

Nice (NICE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this software company have returned -16.3% over the past month versus the Zacks S&P 500 composite's +4% change. The Zacks Internet - Software industry, to which Nice belongs, has lost 3% over this period. Now the key question is: Where could the stock be headed in the near term?While media releases or rumors about a ...

BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced the National Institute for Health and Care Excellence (NICE) has issued guidance that recommends IMCIVREE® (setmelanotide) as an option for treating obesity and the control of hunger (hyperphagia) in genetically confirmed Bardet-Biedl syndrome (BBS) i ...

A downtrend has been apparent in Nice (NICE) lately with too much selling pressure. The stock has declined 10.6% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting w ...

Nice (NICE) reported adjusted earnings of $2.58 per share in first-quarter 2024, beating the Zacks Consensus Estimate by 5.31% and increasing 27% year over year.Non-GAAP revenues of $659 million trumped the consensus mark by 0.69% and rose 15% year over year. The uptick was primarily driven by the continued strength of its cloud business and the ongoing expansion of its customer base.Revenues in Americas were $559 million, up 18% year over year. The same in EMEA was $67 million in the reported quarter, up 7 ...